Replies to post #434170 on NorthWest Biotherapeutics Inc (NWBO)

[hoffmann6383]

Well, we are in the quiet period whether we ignore it or not. Your update would do nothing for the SP. Our SP is not reflective of the value in NWBO. An analysis of the daily trades will tell you that.

[The Danish Dude]

And what if their strategy actually involved not announcing this beforehand?

Announcing gives the opposition the possibility to prepare.

We know from ASM 2019, that NWBO will do everything in their power, not to give “the opposition” an inch of an opportunity to react, when TLD hits. That they have also prepared for this.

NWBO would’ve traded below $1 with TLD 9-10 months ago.

Nothing is lost. Not time. Not progress.

NWBO has by going silent, gained TLD is dry powder.

Incredible it can be so difficult to see.

[martyDg]

Exactly!

[biosectinvestor]

Quiet periods are about best practice in many instances, not requirements. And the reason is to avoid problems with the SEC, FDA and plaintiff’s lawyers, and those problems are very easy to stumble into without intending to do so. THAT is why there is a quiet period. Best practice, recommended by their counsel I have no doubt but also generally by the National Academy of Sciences.

Do the notion that they do not need to do it, I get, is driven by inpatio very but it is very real and very important that they do it as they have chosen. There are too many variables that can be used to suggest that they did something or said something wrong, not to wait for what would be a more careful and complete explanation of their trial results. I’d rather they are careful in this case because we know this trial is very complex and stumbling would be extremely easy.